Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Drug management in chronic schizophrenia.

Tune LE, McHugh PR, Coyle JT.

Johns Hopkins Med J. 1982 Jan;150(1):45-8. No abstract available.

PMID:
7054584
2.

Effects of chlorpromazine and trifluoperazine on the activity of chronic schizophrenics.

Jones IH, Pikler N.

Br J Psychiatry. 1971 Nov;119(552):545-6. No abstract available.

PMID:
4944663
3.

Acute paranoid schizophrenia. (Treatment with chlorpromazine, trifluoperazine and placebo).

Reardon JD, Abrams S.

Dis Nerv Syst. 1966 Apr;27(4):265-70. No abstract available.

PMID:
5936140
4.

Neuroleptic therapy for chronic schizophrenia.

Ayd FJ Jr.

Dis Nerv Syst. 1972 Jan;33(1):35-9. No abstract available.

PMID:
5059687
5.

[Comparative study of trifluperidol and trifluoperazine in the treatment of acute schizophrenia].

Gauthier R, Hillel J, Bordeleau JM, T├ętreault L.

Union Med Can. 1967 Aug;96(8):936-43. French. No abstract available.

PMID:
5618135
6.

Intermittent pharmacotherapy in chronic schizophrenia.

Prien RF, Gillis RD, Caffey EM Jr.

Hosp Community Psychiatry. 1973 May;24(5):317-22. No abstract available.

PMID:
4574574
7.

Ultracentrifugal serum proteins in schizophrenia.

Bishop MP, Gallant DM, Heath RG, Hollister LE.

Arch Gen Psychiatry. 1966 Oct;15(4):337-40. No abstract available.

PMID:
6005916
8.

A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia.

Morton MR.

Am J Psychiatry. 1968 May;124(11):1585-8. No abstract available.

PMID:
4869439
9.

Are antipsychotic drugs interchangeable?

Gardos G.

J Nerv Ment Dis. 1974 Nov;159(5):343-8. No abstract available.

PMID:
4612111
10.

Response in chronic schizophrenia correlated with chlorpromazine, 7-OH-chlorpromazine and chlorpromazine sulfoxide levels.

Chetty M, Pillay VL, Moodley SV, Miller R.

Eur Neuropsychopharmacol. 1996 May;6(2):85-91.

PMID:
8791032
11.

Drug induced dystonia tarda: treatment with L-dopa.

Keegan DL, Rajput AH.

Dis Nerv Syst. 1973 Mar;34(3):167-9. No abstract available.

PMID:
4146031
12.

[A therapeutic pathomorphosis of schizophrenia proceeding with paranoid disorders].

Ozola MIa.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1970;70(4):600-5. Russian. No abstract available.

PMID:
5497116
13.

Alterations of evoked potentials in psychotic patients under the influence of chlorpromazine and trifluoperazine.

Kopylova TV.

Electroencephalogr Clin Neurophysiol. 1969 Oct;27(4):449. No abstract available.

PMID:
4186762
14.
15.
16.

Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: the value of less sedative antipsychotic agents.

Fish B, Campbell M, Shapiro T, Floyd A Jr.

Curr Ther Res Clin Exp. 1969 Oct;11(10):589-95. No abstract available.

PMID:
4981301
17.

Visual evoked responses and mental status of schizophrenics.

Heninger G, Speck LB.

Arch Gen Psychiatry. 1966 Oct;15(4):419-26. No abstract available.

PMID:
5954718
18.
19.

[Use of triphthazine in the treatment of mentae disorders].

Gurowitsch IJ, Awruzki GJ.

Psychiatr Neurol Med Psychol (Leipz). 1975 May;27(5):284-91. German.

PMID:
812131
20.

Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics.

Cooper SF, Albert JM, Hillel J, Caille G.

Curr Ther Res Clin Exp. 1973 Feb;15(2):73-7. No abstract available.

PMID:
4632509
Items per page

Supplemental Content

Write to the Help Desk